Multiple tissues express alpha 1-antitrypsin in transgenic mice and man
- PMID: 3260605
- PMCID: PMC303472
- DOI: 10.1172/JCI113580
Multiple tissues express alpha 1-antitrypsin in transgenic mice and man
Abstract
Hepatocytes are considered to be the predominant source of alpha 1-antitrypsin (AAT), the major antiprotease in human plasma. The development of emphysema in the hereditary PiZ AAT deficiency state suggests that inhibition of leukocyte elastase in the lung is a major function of this protein. In addition, patients with AAT deficiency are at increased risk for developing cholestasis in infancy and chronic liver disease as adults. The mechanism for hepatic cell injury, however, is not understood. Transgenic mice that express the normal human AAT gene demonstrate abundant AAT in hepatocytes and specific cell types of numerous nonhepatic tissues. Immunoperoxidase techniques have previously disclosed AAT in many of the cell types seen in transgenic mice; however, the issue of local synthesis vs. endocytosis in these cell types has remained unresolved. In this study, AAT mRNA was seen in a variety of tissues in the transgenic mouse. Immunoelectron microscopy of renal tubular and small intestinal epithelial cells in the transgenic mice demonstrated AAT within the cisternae of the rough endoplasmic reticulum, as in hepatocytes. These findings support the possibility of local synthesis in the various cell types. The results suggest that in addition to maintaining tissue integrity in the lung, the protease/antiprotease balance may have physiological functions in other organs as well.
Similar articles
-
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.J Clin Invest. 1989 Apr;83(4):1183-90. doi: 10.1172/JCI113999. J Clin Invest. 1989. PMID: 2784798 Free PMC article.
-
Elevated synthesis of human alpha 1-antitrypsin hinders the secretion of murine alpha 1-antitrypsin from hepatocytes of transgenic mice.J Biol Chem. 1989 Sep 15;264(26):15696-700. J Biol Chem. 1989. PMID: 2788654
-
Genetic control of human alpha-1-antitrypsin.Mol Biol Med. 1989 Apr;6(2):127-35. Mol Biol Med. 1989. PMID: 2693888 Review.
-
Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.Liver Int. 2015 Jan;35(1):198-206. doi: 10.1111/liv.12504. Epub 2014 Mar 11. Liver Int. 2015. PMID: 24529185
-
Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.Bull World Health Organ. 1997;75(5):397-415. Bull World Health Organ. 1997. PMID: 9447774 Free PMC article. Review.
Cited by
-
Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.J Clin Invest. 1989 Apr;83(4):1183-90. doi: 10.1172/JCI113999. J Clin Invest. 1989. PMID: 2784798 Free PMC article.
-
Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs.Mol Biol Cell. 2002 Aug;13(8):2639-50. doi: 10.1091/mbc.e02-02-0068. Mol Biol Cell. 2002. PMID: 12181335 Free PMC article.
-
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences.Biomedicines. 2023 Jul 12;11(7):1961. doi: 10.3390/biomedicines11071961. Biomedicines. 2023. PMID: 37509601 Free PMC article. Review.
-
Liver gene therapy: The magic bullet for the sick lung.Mol Ther Methods Clin Dev. 2022 Jun 15;26:72-73. doi: 10.1016/j.omtm.2022.05.004. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 35782595 Free PMC article. No abstract available.
-
Is fibrosing colonopathy an immune mediated disease?Arch Dis Child. 1997 Jul;77(1):66-70. doi: 10.1136/adc.77.1.66. Arch Dis Child. 1997. PMID: 9279159 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous